Info

Investor Relations

Investor Overview

Mission The TR SoftRay PLC utilizes their over many years acquired expertise in the field of X-ray technology to fill a huge gap in the medical and therapeutic care. This gap has been closed in the past with surgical and chemotherapeutic measures, which are subject to high risks and disproportionate costs. Thanks to our T-60 / with its latest technology, a gentle radiation to the patient is possible today and the success is sustainable. Vision The growth rhythm of the company will depend on how quickly the benefits of radiation therapy are able to penetrate into the consciousness of doctors and patients. We will be accelerating this process with various supportive measures, such as seminars, websites, TV health broadcasts, PR articles, etc. In a first phase, the Swiss market is covered with 20 strategically placed plants. In the second step of corporate development company-owned mobile or fix installed competence centers will be built, offering exclusively dermatological radiotherapy and thus do not compete with referring physicians.

Investor Overview

Mission The TR SoftRay PLC utilizes their over many years acquired expertise in the field of X-ray technology to fill a huge gap in the medical and therapeutic care. This gap has been closed in the past with surgical and chemotherapeutic measures, which are subject to high risks and disproportionate costs. Thanks to our T-60 / with its latest technology, a gentle radiation to the patient is possible today and the success is sustainable. Vision The growth rhythm of the company will depend on how quickly the benefits of radiation therapy are able to penetrate into the consciousness of doctors and patients. We will be accelerating this process with various supportive measures, such as seminars, websites, TV health broadcasts, PR articles, etc. In a first phase, the Swiss market is covered with 20 strategically placed plants. In the second step of corporate development company-owned mobile or fix installed competence centers will be built, offering exclusively dermatological radiotherapy and thus do not compete with referring physicians.